Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase–bright stem cells in patients with ischemic heart failure
Tài liệu tham khảo
Abdel-Latif, 2007, Adult bone marrow–derived cells for cardiac repair: a systematic review and meta-analysis, Arch Intern Med, 167, 989, 10.1001/archinte.167.10.989
Beeres, 2006, Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results, Am Heart J, 152, 684.e11, 10.1016/j.ahj.2006.07.018
Briguori, 2006, Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina, Am Heart J, 151, 674, 10.1016/j.ahj.2005.04.033
Burt, 2008, Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases, JAMA, 299, 925, 10.1001/jama.299.8.925
Fuchs, 2006, Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease, Am J Cardiol, 97, 823, 10.1016/j.amjcard.2005.09.132
Heeschen, 2004, Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease, Circulation, 109, 1615, 10.1161/01.CIR.0000124476.32871.E3
Lipinski, 2007, Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials, J Am Coll Cardiol, 50, 1761, 10.1016/j.jacc.2007.07.041
Losordo, 2007, Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial, Circulation, 115, 3165, 10.1161/CIRCULATIONAHA.106.687376
Martin-Rendon, 2008, Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review, Eur Heart J, 29, 1807, 10.1093/eurheartj/ehn220
Perin, 2003, Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure, Circulation, 107, 2294, 10.1161/01.CIR.0000070596.30552.8B
Perin, 2004, Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy, Circulation, 110, II213, 10.1161/01.CIR.0000138398.77550.62
Tse, 2006, Safety of catheter-based intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis, Am J Cardiol, 98, 60, 10.1016/j.amjcard.2006.01.056
Tse, 2007, Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial), Eur Heart J, 28, 2998, 10.1093/eurheartj/ehm485
Storms, 1999, Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity, Proc Natl Acad Sci U S A, 96, 9118, 10.1073/pnas.96.16.9118
Gentry, 2007, Isolation of early hematopoietic cells, including megakaryocyte progenitors, in the ALDH-bright cell population of cryopreserved, banked UC blood, Cytotherapy, 9, 569, 10.1080/14653240701466347
Gentry, 2007, Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy, Cytotherapy, 9, 259, 10.1080/14653240701218516
Capoccia, 2009, Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity, Blood, 113, 5340, 10.1182/blood-2008-04-154567
Lin, 2006, Automated quantification of myocardial ischemia and wall motion defects by use of cardiac SPECT polar mapping and 4-dimensional surface rendering, J Nucl Med Technol, 34, 3
Krause, 2009, Endocardial electrogram analysis after intramyocardial injection of mesenchymal stem cells in the chronic ischemic myocardium, Pacing Clin Electrophysiol, 32, 1319, 10.1111/j.1540-8159.2009.02483.x
Silva, 2004, Catheter-based transendocardial delivery of autologous bone-marrow–derived mononuclear cells in patients listed for heart transplantation, Tex Heart Inst J, 31, 214
Beitnes, 2009, Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study, Heart, 95, 1983, 10.1136/hrt.2009.178913
Pasquet, 2009, Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor–mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct, Cytotherapy, 11, 1002, 10.3109/14653240903164963
Sondergaard, 2010, Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction, J Transl Med, 8, 24, 10.1186/1479-5876-8-24
van Ramshorst, 2009, Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial, JAMA, 301, 1997, 10.1001/jama.2009.685
Losordo, 2011, Intramyocardial, autologous CD34+ cell therapy for refractory angina, Circ Res, 109, 428, 10.1161/CIRCRESAHA.111.245993
Mancini, 1991, Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure, Circulation, 83, 778, 10.1161/01.CIR.83.3.778
Florea, 2000, Prognostic value of changes over time in exercise capacity and echocardiographic measurements in patients with chronic heart failure, Eur Heart J, 21, 146, 10.1053/euhj.2000.1737